Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

NCT00767221 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

IGA Nephropathy

Interventions

DRUG: Budesonide

Sponsor

Calliditas Therapeutics AB

Collaborators

[object Object]